COARE Biotechnology, Inc. logo

COARE Biotechnology, Inc.

We develop innovative new anti-cancer therapies directed against a novel molecular target, whose mechanism of action involves multi-pathway. COARE Biotechnology is preclinical stage company, developing anti-cancer drugs that eliminate cancer stem cells, and also designs biomarkers for the detection of oncological protiens.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://coarebiotechnology.com
Founded2010
Disease Focus
Development Stage
STOCK CODENon Listed
Address
800 Research Pkwy Suite 350B, OK 73104
Oklahoma City
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/coare-biotechnology” connections=”true” suffix=””]

COAREs technology platform utilizes its proprietary siRNA mediated delivery platform and company is also developing panels of monoclonal antibodies against key stem cell signaling molecules expressed on tumor initiating cells.

COARE Biotechnology key partners includes Oklahoma SBIR Collaborative Resources (OSCR) and Oklahoma Center for the Advancement of Science and Technology (OCAST).

In Aug 2013, COARE Biotechnology was awarded with a $220,099 grant by the NIH to develop a new treatment for Pancreatic ductal adenocarcinoma (PDAC).